相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration A Randomized Pivotal Phase 2/3 Trial
Glenn J. Jaffe et al.
OPHTHALMOLOGY (2021)
Cellular senescence in the aging retina and developments of senotherapies for age-related macular degeneration
Keng Siang Lee et al.
JOURNAL OF NEUROINFLAMMATION (2021)
Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration
Rahul N. Khurana et al.
OPHTHALMOLOGY (2021)
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
Pravin U. Dugel et al.
OPHTHALMOLOGY (2020)
Intravitreal Combined Aflibercept plus Anti-Platelet-Derived Growth Factor Receptor β for Neovascular Age-Related Macular Degeneration Results of the Phase 2 CAPELLA Trial
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2020)
Connexin Hemichannel Block Using Orally Delivered Tonabersat Improves Outcomes in Animal Models of Retinal Disease
Mohd Nasir Mat Nor et al.
NEUROTHERAPEUTICS (2020)
Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles
Hiroki Tsujinaka et al.
NATURE COMMUNICATIONS (2020)
Risuteganib-a novel integrin inhibitor for the treatment of non-exudative (dry) age-related macular degeneration and diabetic macular edema
Lincoln T. Shaw et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
The TSPO-NOX1 axis controls phagocyte-triggered pathological angiogenesis in the eye
Anne Wolf et al.
NATURE COMMUNICATIONS (2020)
Predicting conversion to wet age-related macular degeneration using deep learning
Jason Yim et al.
NATURE MEDICINE (2020)
Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration 52-Week Results of Phase 3 Randomized Controlled Study
Derek Kunimoto et al.
OPHTHALMOLOGY (2020)
Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration The STAIRWAY Phase 2 Randomized Clinical Trial
Arshad M. Khanani et al.
JAMA OPHTHALMOLOGY (2020)
Treatment with interleukin-33 is non-toxic and protects retinal pigment epithelium in an ageing model of outer retinal degeneration
Alison J. Clare et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Safety and Efficacy of Subretinally Administered Palucorcel for Geographic Atrophy of Age-Related Macular Degeneration Phase 2b Study
Jeffrey S. Heier et al.
OPHTHALMOLOGY RETINA (2020)
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration Results from the Randomized Phase 2 Ladder Clinical Trial
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2019)
A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration
James T. Handa et al.
NATURE COMMUNICATIONS (2019)
Complement system and age-related macular degeneration: drugs and challenges
Jiali Wu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration
Leon von der Emde et al.
SCIENTIFIC REPORTS (2019)
An in vitro Assessment of Thermo-Reversible Gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration
Priyanka Bhatt et al.
AAPS PHARMSCITECH (2019)
Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease
Yusaku Matsuda et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trial
Antonia M. Joussen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Mapping Physical Tumor Microenvironment and Drug Delivery
Hadi T. Nia et al.
CLINICAL CANCER RESEARCH (2019)
IL-33 deficiency causes persistent inflammation and severe neurodegeneration in retinal detachment
Josy Augustine et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Clinical-grade stem cell-derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs
Ruchi Sharma et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
InflammAging at Ocular Surface: Clinical and Biomolecular Analyses in Healthy Volunteers
Antonio Di Zazzo et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2019)
Artificial intelligence-based decision-making for age-related macular degeneration
De-Kuang Hwang et al.
THERANOSTICS (2019)
Cell penetrating peptides in ocular drug delivery: State of the art
S. Pescina et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration
Lyndon da Cruz et al.
NATURE BIOTECHNOLOGY (2018)
Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration A Randomized Clinical Trial
Philip J. Rosenfeld et al.
OPHTHALMOLOGY (2018)
A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration
Amir H. Kashani et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration Chroma and Spectri Phase 3 Randomized Clinical Trials
Frank G. Holz et al.
JAMA OPHTHALMOLOGY (2018)
Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model
Balasubramaniam Annamalai et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2018)
Modulation of three key innate immune pathways for the most common retinal degenerative diseases
Isha Akhtar-Schaefer et al.
EMBO MOLECULAR MEDICINE (2018)
Lessons from Recent Phase III Trial Failures: Don't Design Phase III Trials Based on Retrospective Subgroup Analyses from Phase II Trials
Philip J. Rosenfeld et al.
OPHTHALMOLOGY (2018)
Systemic immunosuppression and risk of age-related macular degeneration
Harpal S. Sandhu et al.
PLOS ONE (2018)
Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration
David Callanan et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2018)
A Randomized Phase 2 Study of an Anti-Amyloid β Monoclonal Antibody in Geographic Atrophy Secondary to Age-Related Macular Degeneration
Philip J. Rosenfeld et al.
OPHTHALMOLOGY RETINA (2018)
A Perspective of AMD Through the Eyes of Immunology
David A. Copland et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2018)
Interleukin-33 regulates tissue remodelling and inhibits angiogenesis in the eye
Sofia Theodoropoulou et al.
JOURNAL OF PATHOLOGY (2017)
Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial
Jeffrey S. Heier et al.
LANCET (2017)
Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration
M. Mandai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration
Glenn J. Jaffe et al.
OPHTHALMOLOGY (2017)
Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial
Pravin U. Dugel et al.
OPHTHALMOLOGY (2017)
Pharmacokinetic aspects of retinal drug delivery
Eva M. del Amo et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2017)
Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration
Brian L. Yaspan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
An Overview of the Fovista and Rinucumab Trials and the Fate of Anti-PDGF Medications
Evan N. Dunn et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2017)
iPSC-Derived Retina Transplants Improve Vision in rd1 End-Stage Retinal-Degeneration Mice (vol 8, pg 69, 2017)
Michiko Mandai et al.
STEM CELL REPORTS (2017)
Experience With a Subretinal Cell-based GossMark Therapy in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Allen C. Ho et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2017)
Topical Delivery of Anti-VEGF Drugs to the Ocular Posterior Segment Using Cell-Penetrating Peptides
Felicity de Cogan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
Chronic, Systemic Interleukin-18 Does Not Promote Macular Degeneration or Choroidal Neovascularization
Scott W. Canna et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
Interferon-beta signaling in retinal mononuclear phagocytes attenuates pathological neovascularization
Anika Lueckoff et al.
EMBO MOLECULAR MEDICINE (2016)
IBI302, a promising candidate for AMD treatment, targeting both the VEGF and complement system with high binding affinity in vitro and effective targeting of the ocular tissue in healthy rhesus monkeys
Xinyi Ren et al.
EXPERIMENTAL EYE RESEARCH (2016)
Subretinal implantation of a monolayer of human embryonic stem cell-derived retinal pigment epithelium: a feasibility and safety study in Yucatan minipigs
Michael J. Koss et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2016)
IL-33 amplifies an innate immune response in the degenerating retina
Hongkang Xi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration
Glenn J. Jaffe et al.
OPHTHALMOLOGY (2016)
Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration
Frank G. Holz et al.
OPHTHALMOLOGY (2016)
Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration
Ian J. Constable et al.
EBIOMEDICINE (2016)
Interleukin-33 in health and disease
Foo Yew Liew et al.
NATURE REVIEWS IMMUNOLOGY (2016)
HL-217, a new topical anti-angiogenic agent, inhibits retinal vascular leakage and pathogenic subretinal neovascularization in Vldlr-/- mice
Junghyun Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Targeting translocator protein (18 kDa) (TSPO) dampens pro-inflammatory microglia reactivity in the retina and protects from degeneration
Rebecca Scholz et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial
Elizabeth P. Rakoczy et al.
LANCET (2015)
RIKEN suspends first clinical trial involving induced pluripotent stem cells
Ken Garber
NATURE BIOTECHNOLOGY (2015)
Clinical Evaluation of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections in Subjects with Neovascular Age-Related Macular Degeneration
Karl G. Csaky et al.
OPHTHALMOLOGY (2015)
PHASE II, RANDOMIZED, PLACEBO-CONTROLLED, 90-DAY STUDY OF EMIXUSTAT HYDROCHLORIDE IN GEOGRAPHIC ATROPHY ASSOCIATED WITH DRY AGE-RELATED MACULAR DEGENERATION
Pravin U. Dugel et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)
GEOGRAPHIC ATROPHY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Luna Xu et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)
Immune mechanisms in inflammatory and degenerative eye disease
Victor L. Perez et al.
TRENDS IN IMMUNOLOGY (2015)
IL10-driven STAT3 signalling in senescent macrophages promotes pathological eye angiogenesis
Rei Nakamura et al.
NATURE COMMUNICATIONS (2015)
Author Response: The Role of IL-18 in the Treatment of AMD
Sarah L. Doyle et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
IL-18 Immunotherapy for Neovascular AMD: Tolerability and Efficacy in Nonhuman Primates
Sarah L. Doyle et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Treatment of Exudative Age-Related Macular Degeneration with a Designed Ankyrin Repeat Protein that Binds Vascular Endothelial Growth Factor: a Phase I/II Study
Eric H. Souied et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2014)
Pazopanib eye drops: a randomised trial in neovascular age-related macular degeneration
Ronald Danis et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2014)
Interleukin-18 Has Antipermeablity and Antiangiogenic Activities in the Eye: Reciprocal Suppression With VEGF
Jikui Shen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
IL-18 is not therapeutic for neovascular age-related macular degeneration
Yoshio Hirano et al.
NATURE MEDICINE (2014)
Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration
Zohar Yehoshua et al.
OPHTHALMOLOGY (2014)
IL-18 Attenuates Experimental Choroidal Neovascularization as a Potential Therapy for Wet Age-Related Macular Degeneration
Sarah L. Doyle et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Immunomodulatory drugs: Oral and systemic adverse effects
Antonio Bascones-Martinez et al.
MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL (2014)
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
Wan Ling Wong et al.
LANCET GLOBAL HEALTH (2014)
Characterization of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cell Sheets Aiming for Clinical Application
Hiroyuki Kamao et al.
STEM CELL REPORTS (2014)
Interleukin-18 Induces Retinal Pigment Epithelium Degeneration in Mice
Ryo Ijima et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Treatment of Diabetic Macular Edema With a Designed Ankyrin Repeat Protein That Binds Vascular Endothelial Growth Factor: A Phase I/II Study
Peter A. Campochiaro et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
K. Ghasemi Falavarjani et al.
EYE (2013)
The Vitreous Humor As a Barrier to Nanoparticle Distribution
Jenifer Mains et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2013)
Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
Soraya Rofagha et al.
OPHTHALMOLOGY (2013)
NLRP3 Inflammasome Blockade Inhibits VEGF-A-Induced Age-Related Macular Degeneration
Alexander G. Marneros
CELL REPORTS (2013)
Age-Related Changes and Diseases of the Ocular Surface and Cornea
Ilene K. Gipson
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans
Tim U. Krohne et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components
Sarah L. Doyle et al.
NATURE MEDICINE (2012)
Low-Dose Lipopolysaccharide Pretreatment Suppresses Choroidal Neovascularization via IL-10 Induction
Nagakazu Matsumura et al.
PLOS ONE (2012)
Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats
Yousef Yafai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
A Non Membrane-Targeted Human Soluble CD59 Attenuates Choroidal Neovascularization in a Model of Age Related Macular Degeneration
Siobhan M. Cashman et al.
PLOS ONE (2011)
Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration
Jin-Dong Ding et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Drug-Eluting Intraocular Lenses
Clara Gonzalez-Chomon et al.
MATERIALS (2011)
A RANDOMIZED PILOT STUDY OF SYSTEMIC IMMUNOSUPPRESSION IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION WITH CHOROIDAL NEOVASCULARIZATION
Robert B. Nussenblatt et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Suppression and Regression of Choroidal Neovascularization by the Multitargeted Kinase Inhibitor Pazopanib
Kyoichi Takahashi et al.
ARCHIVES OF OPHTHALMOLOGY (2009)
rAAV.sFlt-1 Gene Therapy Achieves Lasting Reversal of Retinal Neovascularization in the Absence of a Strong Immune Response to the Viral Vector
Chooi-May Lai et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
A dose-escalation study of recombinant human interleukin-18 using two different schedules of administration in patients with cancer
Michael J. Robertson et al.
CLINICAL CANCER RESEARCH (2008)
Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies:: Anti-amyloid-β antibody attenuates pathologies in an age-related macular degeneration mouse model
Jin-Dong Ding et al.
VISION RESEARCH (2008)
Evaluation of adenovirus-delivered human CD59 as a potential therapy for AMD in a model of human membrane attack complex formation on murine RPE
Kasmir Ramo et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease
Raymond D. Lund et al.
STEM CELLS (2007)
Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction
Peter J. Coffey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Complement C3 variant and the risk of age-related macular degeneration
John R. W. Yates et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury
Kazuaki Nishijima et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration
Nalini S. Bora et al.
JOURNAL OF IMMUNOLOGY (2007)
Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease (vol 25, pg 602, 2007)
Raymond D. Lund et al.
STEM CELLS (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: Role of factor B and factor H
Nalini S. Bora et al.
JOURNAL OF IMMUNOLOGY (2006)
Drusen complement components C3a and C5a promote choroidal neovascularization
M Nozaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The potential role of amyloid β in the pathogenesis of age-related macular degeneration
T Yoshida et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration
PJ Rosenfeld et al.
OPHTHALMIC SURGERY LASERS & IMAGING (2005)
Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration - Twelve-week results of an uncontrolled open-label clinical study
S Michels et al.
OPHTHALMOLOGY (2005)
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration
GS Hageman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization
PS Bora et al.
JOURNAL OF IMMUNOLOGY (2005)
Characterization of β amyloid assemblies in drusen:: the deposits associated with aging and age-related macular degeneration
DH Anderson et al.
EXPERIMENTAL EYE RESEARCH (2004)
Pegaptanib for neovascular age-related macular degeneration
ES Gragoudas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Squalamine lactate reduces choroidal neovascularization in a laser-injury model in the rat
TA Ciulla et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2003)
VEGF-Trap: A VEGF blocker with potent antitumor effects
J Holash et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
IFN-α antibodies in patients with age-related macular degeneration treated with recombinant human IFN-α2a
C Ross et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2002)
Complement activation and inflammatory processes in drusen formation and age related macular degeneration
LV Johnson et al.
EXPERIMENTAL EYE RESEARCH (2001)
分享论文
